On Chemball
My Chemball
+86-571-8627 3270
Jiangsu Simcere Pharmaceutical Co., Ltd.
Jiangsu Simcere Pharmaceutical Co., Ltd.
Main Products:
Posaconazole / Diosmectite / Zanamivir / Palonosetron Hydrochloride / Pemetrexed Disodium / Bendamustine HCl / Palbociclib / Cabozantinib Malate / Ibrutinib / Edoxaban(Tosylate Monohydrate) / Bedaquiline Fumarate / Apremilast
ABOUT US
Jiangsu Xiansheng Pharmaceutical Co., Ltd. is a pharmaceutical company rapidly transforming to innovation and R & D drive. It has been approved by the Ministry of science and technology to build the "State Key Laboratory of translational medicine and innovative drugs". The company focuses on the three major diseases of tumor, central nervous system and autoimmunity, and is committed to "enabling patients to use more effective drugs as soon as possible". With excellent R & D and commercialization capabilities, the main products maintain a leading market share in China. Adhering to the R & D strategy of open innovation, the company has become a strategic partner with a number of multinational companies and biotechnology enterprises to promote the realization of the value of global life science achievements in China. At the same time, the company has ranked among the "top 10 pharmaceutical enterprises with innovative power in China" and "top 100 pharmaceutical industries in China" for many consecutive years.
Basic Information
Tax ID
91320000134783346P
Country/Region
Jiangsu, China
Year Established
1995
Registered Capital
CNY 568.8 Million
Business Type
Manufacturing
Total Employees
Over 1000 people
Quality Management Certificate
-
Total Annual Revenue
-
Enterprise Ownership
Private Owned
Is This Your Own Factory
Yes
Summary Up
China's first biological and chemical pharmaceutical company listed on the New York Stock Exchange
PLANT LOCATION
ORGANIZATION UNIT
900 People
R&D Dept
COMPANY ALBUM
CERTIFICATES